Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

PDK1 controls upstream PI3K expression and PIP3 generation.

Dieterle AM, Böhler P, Keppeler H, Alers S, Berleth N, Drießen S, Hieke N, Pietkiewicz S, Löffler AS, Peter C, Gray A, Leslie NR, Shinohara H, Kurosaki T, Engelke M, Wienands J, Bonin M, Wesselborg S, Stork B.

Oncogene. 2014 Jun 5;33(23):3043-53. doi: 10.1038/onc.2013.266. Epub 2013 Jul 29.

PMID:
23893244
2.

Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction.

Alers S, Löffler AS, Paasch F, Dieterle AM, Keppeler H, Lauber K, Campbell DG, Fehrenbacher B, Schaller M, Wesselborg S, Stork B.

Autophagy. 2011 Dec;7(12):1423-33.

3.

Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1.

Manns J, Daubrawa M, Driessen S, Paasch F, Hoffmann N, Löffler A, Lauber K, Dieterle A, Alers S, Iftner T, Schulze-Osthoff K, Stork B, Wesselborg S.

FASEB J. 2011 Sep;25(9):3250-61. doi: 10.1096/fj.10-177527. Epub 2011 Jun 9.

PMID:
21659556
4.

Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop.

Löffler AS, Alers S, Dieterle AM, Keppeler H, Franz-Wachtel M, Kundu M, Campbell DG, Wesselborg S, Alessi DR, Stork B.

Autophagy. 2011 Jul;7(7):696-706. Epub 2011 Jul 1.

PMID:
21460634
5.

Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor.

Dieterle A, Fischer MJ, Link AS, Neuhuber WL, Messlinger K.

Cephalalgia. 2011 Jan;31(1):31-42. doi: 10.1177/0333102410375725. Epub 2010 Jul 5.

PMID:
20974582
6.

AMPK-independent induction of autophagy by cytosolic Ca2+ increase.

Grotemeier A, Alers S, Pfisterer SG, Paasch F, Daubrawa M, Dieterle A, Viollet B, Wesselborg S, Proikas-Cezanne T, Stork B.

Cell Signal. 2010 Jun;22(6):914-25. doi: 10.1016/j.cellsig.2010.01.015. Epub 2010 Jan 28.

PMID:
20114074
7.

The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.

Dieterle A, Orth R, Daubrawa M, Grotemeier A, Alers S, Ullrich S, Lammers R, Wesselborg S, Stork B.

Int J Cancer. 2009 Aug 15;125(4):932-41. doi: 10.1002/ijc.24374.

8.

Release of calcitonin gene-related peptide from the jugular-nodose ganglion complex in rats--a new model to examine the role of cardiac peptidergic and nitrergic innervation.

Strecker T, Koulchitsky S, Dieterle A, Neuhuber WL, Weyand M, Messlinger K.

Neuropeptides. 2008 Oct-Dec;42(5-6):543-50. doi: 10.1016/j.npep.2008.08.002. Epub 2008 Sep 21.

PMID:
18809208
9.

Stimulated release of calcitonin gene-related peptide from the human right atrium in patients with and without diabetes mellitus.

Strecker T, Dieterle A, Reeh PW, Weyand M, Messlinger K.

Peptides. 2006 Dec;27(12):3255-60. Epub 2006 Sep 22.

PMID:
16996168
10.

HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.

D'Addario G, Dieterle A, Torhorst J, Maibach R, Stahel R, Egli F, Lohri A, Cavalli F, Fey M, Ketterer N, Cerny T.

Leuk Lymphoma. 2003 Jan;44(1):133-8.

PMID:
12691153
11.

Differential influence of the E4 adenoviral genes on viral and cellular promoters.

Grave L, Dreyer D, Dieterle A, Leroy P, Michou AI, Doderer C, Pavirani A, Lusky M, Mehtali M.

J Gene Med. 2000 Nov-Dec;2(6):433-43.

PMID:
11199264
12.

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

Christ M, Louis B, Stoeckel F, Dieterle A, Grave L, Dreyer D, Kintz J, Ali Hadji D, Lusky M, Mehtali M.

Hum Gene Ther. 2000 Feb 10;11(3):415-27.

PMID:
10697116
13.

Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.

Lusky M, Grave L, Dieterlé A, Dreyer D, Christ M, Ziller C, Furstenberger P, Kintz J, Hadji DA, Pavirani A, Mehtali M.

J Virol. 1999 Oct;73(10):8308-19.

14.

In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M.

J Virol. 1998 Mar;72(3):2022-32.

15.

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.

Christ M, Lusky M, Stoeckel F, Dreyer D, Dieterlé A, Michou AI, Pavirani A, Mehtali M.

Immunol Lett. 1997 Jun 1;57(1-3):19-25.

PMID:
9232420
16.

Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M.

J Virol. 1996 Jul;70(7):4805-10.

17.

Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.

Imler JL, Chartier C, Dreyer D, Dieterle A, Sainte-Marie M, Faure T, Pavirani A, Mehtali M.

Gene Ther. 1996 Jan;3(1):75-84.

PMID:
8929914
18.

Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter.

Imler JL, Dupuit F, Chartier C, Accart N, Dieterle A, Schultz H, Puchelle E, Pavirani A.

Gene Ther. 1996 Jan;3(1):49-58.

PMID:
8929911
19.

An efficient procedure to select and recover recombinant adenovirus vectors.

Imler JL, Chartier C, Dieterlé A, Dreyer D, Mehtali M, Pavirani A.

Gene Ther. 1995 Jun;2(4):263-8.

PMID:
7552986
20.

Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.

Imler JL, Bout A, Dreyer D, Dieterlé A, Schultz H, Valerio D, Mehtali M, Pavirani A.

Hum Gene Ther. 1995 Jun;6(6):711-21.

PMID:
7548271
21.

Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands.

Jacquot J, Puchelle E, Hinnrasky J, Fuchey C, Bettinger C, Spilmont C, Bonnet N, Dieterle A, Dreyer D, Pavirani A, et al.

Eur Respir J. 1993 Feb;6(2):169-76.

PMID:
7680322
22.

[Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].

Gratwohl A, Dazzi H, Tichelli A, Stebler C, Wernli M, Thomssen C, Kim I, Dieterle A, Obrist R, Stern A, et al.

Schweiz Med Wochenschr. 1991 Mar 23;121(12):413-7. German.

PMID:
2028244
23.

Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study.

Dieterle A, Gratwohl A, Ritz R, Obrecht JP, Obrist R.

Ann Oncol. 1991 Jan;2(1):69-70. No abstract available.

PMID:
2009237
24.

Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.

Jallat S, Perraud F, Dalemans W, Balland A, Dieterle A, Faure T, Meulien P, Pavirani A.

EMBO J. 1990 Oct;9(10):3295-301.

25.

Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.

Dieterle A, Gratwohl A, Nizze H, Huser B, Mihatsch MJ, Thiel G, Tichelli A, Signer E, Nissen C, Speck B.

Transplantation. 1990 Jun;49(6):1093-100.

PMID:
2193442
26.

Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.

Tichelli A, Gratwohl A, Berger C, Lori A, Würsch A, Dieterle A, Thomssen C, Nissen C, Holdener E, Speck B.

Blut. 1989 Jan;58(1):15-9.

PMID:
2644994
27.

Irradiated donor buffy coat following T cell-depleted bone marrow transplants.

Gratwohl A, Tichelli A, Würsch A, Dieterle A, Lori A, Thomssen C, Baldomero H, de Witte T, Nissen C, Speck B.

Bone Marrow Transplant. 1988 Nov;3(6):577-82.

PMID:
3063326
28.

Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine.

Dieterle A, Abeywickrama K, von Graffenried B.

Transplant Proc. 1988 Jun;20(3 Suppl 4):349-55. No abstract available.

PMID:
3381297
29.

Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques.

de la Salle H, Altenburger W, Elkaim R, Dott K, Dieterlé A, Drillien R, Cazenave JP, Tolstoshev P, Lecocq JP.

Nature. 1985 Jul 18-24;316(6025):268-70.

PMID:
4040611

Supplemental Content

Loading ...
Support Center